← FDA Drug Approvals (Drugs@FDA)

ATRIPLA

NDA · New Drug Application · Sponsor: GILEAD SCIENCES · Approved 2006-07-12

Drug application

FDA Application #

NDA021937

Application type

New Drug Application

Brand name

ATRIPLA

Generic name

Efavirenz

Active ingredients

EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

GILEAD SCIENCES

First approval

2006-07-12

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown